| Literature DB >> 31454198 |
Majid Basirat1, Mohsen Ziyaeifard2, Farhad Gorjipour2, Mohammad Javad Mehrabanian3, Seyed Hassan Attarzadeh2, Majid Nekoofard2, Meysam Mortazian4.
Abstract
OBJECTIVES: Postoperative arrhythmia is an important complication of coronary artery bypass grafting (CABG) surgeries among patients. It seems that opioid usage is implicated in the pathogenesis of this condition due to its impacts on different organ systems, such as the autonomic nervous system. The present study was performed to investigate the effect of opium use on postoperative arrhythmia in patients undergoing CABG surgery.Entities:
Keywords: Arrhythmias, Cardiac; Central Venous Pressure; Coronary Artery Bypass; Epinephrine; Opium Dependence; Postoperative Period
Mesh:
Substances:
Year: 2019 PMID: 31454198 PMCID: PMC6713381 DOI: 10.21470/1678-9741-2018-0392
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Inotropic and anticoagulant drug usage between study population with and without postoperative arrhythmia.
| POA (+) | POA (-) | ||
|---|---|---|---|
| Epinephrine in OR | 0.77±0.42 | 0.84±0.37 | 0.02 |
| Epinephrine in ICU | 0.74±0.44 | 0.83±0.37 | 0.11 |
| Norepinephrine in OR | 1±0.001 | 0.98±0.11 | 0.41 |
| Norepinephrine in ICU | 1±0.001 | 0.97±0.11 | 0.41 |
| Dopamine in OR | 0.94±0.24 | 0.98±0.12 | 0.01 |
| Dopamine in ICU | 0.96±0.17 | 0.98±0.14 | 0.53 |
| Milrinone in OR | 0.97±0.17 | 0.99±0.09 | 0.12 |
| Milrinone in ICU | 1.01±0.02 | 0.99±0.09 | 0.46 |
| Dobutamine in OR | 0.97±0.17 | 0.98±0.11 | 0.21 |
| Dobutamine in ICU | 1.0±0.001 | 0.99±0.08 | 0.55 |
P-value was calculated according to independent Student's t-test
ICU=intensive care unit; OR=operating room; POA=postoperative arrhythmia
Inotropic and anticoagulant drug usage between study population.
| Addict patients | Non-addict patients | ||
|---|---|---|---|
| Epinephrine in OR | 0.92±0.27 | 0.78±0.41 | 0.004 |
| Epinephrine in ICU | 1±0.001 | 0.98±0.11 | 0.001 |
| Norepinephrine in OR | 1±0.001 | 0.11±0.98 | 0.263 |
| Norepinephrine in ICU | 1±0.001 | 0.97±0.11 | 0.263 |
| Dopamine in OR | 1±0.001 | 0.97±0.16 | 0.091 |
| Dopamine in ICU | 1±0.001 | 0.96±0.16 | 0.091 |
| Milrinone in OR | 0.99±0.09 | 0.98±0.1 | 0.084 |
| Milrinone in ICU | 0.98±0.15 | 0.34±0.91 | 0.97 |
| Dobutamine in OR | 1.0±0.001 | 0.98±0.13 | 0.16 |
| Dobutamine in ICU | 1.0±0.001 | 0.99±0.08 | 0.42 |
P-value was calculated according to independent Student's t-test.
ICU=intensive care unit; OR=operating room
Comparison of demographic variables between addict and non-addict study population.
| Addict patients (n=104) | Non-addict patients (n=332) | ||
|---|---|---|---|
| Age | 60.36±8.69 | 61.49±9.17 | 0.27 |
| BMI | 25.94±4.72 | 26.38±4.49 | 0.41 |
| Sex (male) | 53 (24.7%) | 162 (75.3%) | 0.70 |
| Diabetes | 52 (25.1%) | 155 (74.9%) | 0.56 |
| Hypertension | 62 (24.9%) | 187 (75.1%) | 0.53 |
| Thyroid disorders | 3 (10.7%) | 25 (89.3%) | 0.09 |
| Neurological lesions | 4 (20%) | 16 (80%) | 0.80 |
| Renal lesions | 12 (29.3%) | 29 (70.7%) | 0.40 |
P-value was calculated according to independent Student's t-test and chi-square test.
Fig. 1Frequency percentage of patients with each type of arrhythmia in patients with and without drug addiction. There were no statistically significant differences between the two groups in the arrhythmia type. AF=atrial fibrillation; PVC=premature ventricular contractions
Comparing blood pressure and heart rate among study population in different study points between patients with and without postoperative arrhythmia.
| POA (+) | POA (-) | ||
|---|---|---|---|
| SBP at baseline | 135.36±22.54 | 123.32±19.63 | <0.001 |
| DBP at baseline | 75.18±11.78 | 71.14±12.33 | 0.02 |
| SBP after surgery | 120.74±16.24 | 116.64±18.30 | 0.12 |
| DBP after surgery | 70.64±18.30 | 69.02±11.93 | 0.34 |
| SBP at ICU admission | 119.03±23.86 | 116.43±21.09 | 0.37 |
| DBP at ICU admission | 68.81±11.69 | 66.52±13.49 | 0.21 |
| SBP 6 hours later | 120.59±17.01 | 114.19±14.04 | 0.001 |
| DBP 6 hours later | 69.29±11.39 | 66.05±12.73 | 0.06 |
| SBP 24 hours later | 118.94±17.69 | 115.58±14.73 | 0.09 |
| DBP 24 hours later | 68.62±16.76 | 66.40±11.84 | 0.20 |
| SBP 48 hours later | 121.51±20.55 | 117.28±13.56 | 0.04 |
| DBP 48 hours later | 70.01±11.34 | 66.95±12.62 | 0.07 |
| HR at baseline | 75.65±11.28 | 79.20±11.12 | 0.03 |
| HR after surgery | 82.65±11.28 | 83.97±11.53 | 0.44 |
| HR at ICU admission | 91.66±16.64 | 86.10±13.45 | 0.01 |
| HR 6 hours later | 87.17±16.64 | 84.96±10.83 | 0.17 |
| HR 24 hours later | 86.51±16.50 | 83.23±11.21 | 0.09 |
| HR 48 hours later | 83.38±14.28 | 83.18±10.08 | 0.89 |
| CVP at baseline | 13.73±15.45 | 11.35±9.96 | 0.13 |
| CVP after surgery | 10.42±2.65 | 9.72±2.86 | 0.08 |
| CVP at ICU admission | 10.62±4.21 | 10.38±3.88 | 0.66 |
| CVP 6 hours after surgery | 11.63±3.44 | 12.61±8.36 | 0.35 |
| CVP 24 hours after surgery | 14.32±5.82 | 14.02±12.43 | 0.85 |
| CVP 48 hours after surgery | 14.01±3.78 | 13.01±3.46 | 0.06 |
CVP=central venous pressure; DBP=diastolic blood pressure; HR=heart rate; ICU=intensive care unit; POA=postoperative arrythmia; SBP=systolic blood pressure
Regression analysis for determination of independent predictors of postoperative arrhythmia among study participants.
| Included variables | B | Exp (B) | 95% CI for Exp (B) | ||
|---|---|---|---|---|---|
| Lower | Upper | ||||
| Age | -0.04 | 0.19 | 0.96 | 0.91 | 1.02 |
| Surgery time | -0.003 | 0.45 | 0.99 | 0.99 | 1.005 |
| Diabetes (1) | 0.37 | 0.58 | 1.45 | 0.39 | 5.41 |
| Thyroid (1) | 0.46 | 0.64 | 1.59 | 0.22 | 11.52 |
| Renal (1) | -1.98 | 0.06 | 0.14 | 0.017 | 1.08 |
| Epinephrine in OR | -1.67 | 0.091 | 0.19 | 0.027 | 1.30 |
| Epinephrine in ICU | 2.5 | 0.01 | 12.55 | 1.83 | 86.37 |
| Dopamine in OR | 0.89 | 0.59 | 2.44 | 0.095 | 62.54 |
| Milrinone in OR | 24.68 | 0.99 | 5.24 | 0.001 | 0.99 |
| SBP at baseline | -0.007 | 0.68 | 0.99 | 0.96 | 1.03 |
| DBP at baseline | -0.054 | 0.15 | 0.95 | 0.88 | 1.02 |
| Postoperative SBP | -0.022 | 0.25 | 0.98 | 0.94 | 1.02 |
| SBP 6 hours after surgery | 0.004 | 0.85 | 1.004 | 0.96 | 1.04 |
| DBP 6 hours after surgery | 0.009 | 0.74 | 1.009 | 0.96 | 1.06 |
| SBP 48 hours after surgery | -0.013 | 0.52 | 0.99 | 0.95 | 1.03 |
| DBP 48 hours after surgery | -0.026 | 0.29 | 0.98 | 0.93 | 1.02 |
| HR at baseline | 0.058 | 0.04 | 1.06 | 1.002 | 1.122 |
| HR at ICU | -0.019 | 0.37 | 0.98 | 0.94 | 1.02 |
| HR 6 hours after surgery | 0.040 | 0.24 | 1.04 | 0.97 | 1.11 |
| HR 24 hours after surgery | -0.93 | 0.004 | 0.91 | 0.86 | 0.97 |
| CVP baseline | -0.050 | 0.03 | 0.95 | 0.91 | 0.99 |
| Postoperative CVP | -0.084 | 0.47 | 0.91 | 0.73 | 1.15 |
| CVP 48 hours after surgery | -0.175 | 0.04 | 0.83 | 0.71 | 0.99 |
| Constant | -5.480 | 1 | 0.0040 | - | - |
CVP=central venous pressure; DBP=diastolic blood pressure; HR=heart rate; ICU=intensive care unit; OR=operating room; SBP=systolic blood pressure
| Abbreviations, acronyms & symbols | |
|---|---|
| CAD | = Coronary artery disease |
| CABG | = Coronary artery bypass grafting |
| CPB | = Cardiopulmonary bypass |
| CVD | = Cardiovascular diseases |
| ICU | = Intensive care unit |
| OR | = Operating room |
| WHO | = World Health Organization |
| Author's roles & responsibilities | |
|---|---|
| MB | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MZ | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| FG | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MJM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| SHA | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MN | Substantial contributions to the conception or design of the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |
| MM | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved; final approval of the version to be published |